Reagan Newman
About Reagan Newman
Reagan Newman is a Clinical Research Intern at Koning Corporation, where they develop protocols for clinical trials and translate results into white papers. They hold a Master's degree in Biomedical Engineering and Design from the Georgia Institute of Technology and a Bachelor's degree in Material Science and Engineering from the University of Tennessee, Knoxville.
Work at Koning Corporation
Reagan Newman currently serves as a Clinical Research Intern at Koning Corporation, a position held since 2021. In this role, Newman develops new protocols for upcoming clinical trials, ensuring that they meet necessary standards. Additionally, Newman is responsible for translating clinical trial results and statistics into marketable white papers, contributing to the company's research output and communication efforts.
Education and Expertise
Reagan Newman holds a Master's degree in Biomedical Engineering and Design (MBID) from the Georgia Institute of Technology, completed in 2021. Prior to this, Newman earned a degree in Material Science and Engineering with a focus on Biomaterials from the University of Tennessee, Knoxville, graduating in 2020. This educational background provides a strong foundation in both engineering principles and material science relevant to clinical research.
Background in Research
Before joining Koning Corporation, Reagan Newman gained valuable experience as a Research Intern at Oak Ridge National Laboratory from 2019 to 2020. This role involved hands-on research and contributed to Newman's understanding of scientific protocols and methodologies. Currently, Newman also works as a Graduate Teaching Assistant at Georgia Institute of Technology, a position held since 2020, further enhancing expertise in the field.
Clinical Trial Support and Monitoring
In the role of Clinical Research Intern, Reagan Newman provides support and monitoring for multiple clinical trial sites and studies. This includes ensuring strict adherence to protocols, Good Clinical Practice (GCP), and regulatory requirements during the trials. Newman's responsibilities are crucial for maintaining the integrity and compliance of clinical research activities.